Skip to main content
Signal8
Thompson Tommy G profile photo

Tommy G. Thompson

CIK: 0001324863

Transaction Breakdown

Open Market Buys (P)4 (15.4%)

High conviction signal

Open Market Sales (S)9 (34.6%)

Position reduction

Option Exercises (M)8 (30.8%)

Derivative conversions

Awards (A)5 (19.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

UNITED THERAPEUTICS Corp logo
UTHR

UNITED THERAPEUTICS Corp

Director
TherapeuticsMD, Inc. logo
TXMD

TherapeuticsMD, Inc.

Director
HEALTHPEAK PROPERTIES, INC. logo
DOC

HEALTHPEAK PROPERTIES, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (26 total)

  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Jul 22, 2026
    Award(A)

    Stock Option

    Direct
    1.2K shares-
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Jul 22, 2026
    Award(A)

    Restricted Stock Unit

    Direct
    380 shares-
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Mar 26, 2026
    Sale(S)
    Direct
    311 shares at avg. $540.17$168K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Mar 26, 2026
    Exercise(M)
    Direct
    2K shares at avg. $101.80$204K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Mar 26, 2026
    Sale(S)
    Direct
    275 shares at avg. $537.62$148K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Mar 26, 2026
    Sale(S)
    Direct
    1.4K shares at avg. $539.25$762K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Mar 4, 2026
    Sale(S)
    Direct
    2K shares at avg. $489.42$979K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Mar 4, 2026
    Exercise(M)
    Direct
    2K shares at avg. $101.80$204K
  • TherapeuticsMD, Inc. logo
    TXMD

    TherapeuticsMD, Inc.

    Dec 23, 2025
    Purchase(P)
    Direct
    8.4K shares at avg. $1.67$14K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Dec 18, 2025
    Sale(S)
    Direct
    910 shares at avg. $500.59$456K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Dec 18, 2025
    Exercise(M)
    Direct
    910 shares at avg. $101.80$93K
  • TherapeuticsMD, Inc. logo
    TXMD

    TherapeuticsMD, Inc.

    Nov 3, 2025
    Award(A)

    Restricted Stock Units

    Direct
    8.5K shares-
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Sep 10, 2025
    Exercise(M)
    Direct
    4.6K shares at avg. $229.81$1.0M
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Sep 10, 2025
    Sale(S)
    Direct
    4.6K shares at avg. $403.36$1.8M
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Jul 24, 2025
    Award(A)

    Stock Options

    Direct
    3.7K shares-
  • HEALTHPEAK PROPERTIES, INC. logo
    DOC

    HEALTHPEAK PROPERTIES, INC.

    May 28, 2025
    Purchase(P)
    Direct
    5.8K shares at avg. $17.27$100K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    May 9, 2025
    Sale(S)
    Direct
    2.5K shares at avg. $305.15$763K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    May 9, 2025
    Exercise(M)
    Direct
    2.5K shares at avg. $175.43$439K
  • HEALTHPEAK PROPERTIES, INC. logo
    DOC

    HEALTHPEAK PROPERTIES, INC.

    May 9, 2025
    Purchase(P)
    Direct
    5.7K shares at avg. $17.36$99K
  • HEALTHPEAK PROPERTIES, INC. logo
    DOC

    HEALTHPEAK PROPERTIES, INC.

    Apr 25, 2025
    Award(A)
    Direct
    10.7K shares-
  • TherapeuticsMD, Inc. logo
    TXMD

    TherapeuticsMD, Inc.

    Apr 14, 2025
    Purchase(P)
    Direct
    325 shares at avg. $1.00$325.585
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Mar 24, 2025
    Exercise(M)
    Direct
    2.5K shares at avg. $175.43$439K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Mar 24, 2025
    Sale(S)
    Direct
    2.5K shares at avg. $318.80$797K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Feb 28, 2025
    Sale(S)
    Direct
    2.5K shares at avg. $318.34$796K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Feb 28, 2025
    Exercise(M)
    Direct
    2.5K shares at avg. $175.43$439K

1-25 of 26

About Thompson Tommy G

Thompson Tommy G (SEC CIK 0001324863) files insider reports with the SEC as Director of UNITED THERAPEUTICS Corp (UTHR), Director of TherapeuticsMD, Inc. (TXMD) and Director of HEALTHPEAK PROPERTIES, INC. (DOC).

Signal8 holds 16 ownership filings by Thompson Tommy G, all Form 4s, filed between Feb 20, 2025 and Jul 23, 2026. Those filings report 26 transactions, from Feb 18, 2025 to Jul 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Thompson Tommy G's filings is in SILVER SPRING, MD.

Recent filings by Thompson Tommy G

  • Jul 22, 2026: Grants or awards of UTHR derivative securities (2 lines, Form 4, code A).
  • Mar 26, 2026: Open-market sale of UTHR shares (Form 4, code S).
  • Mar 26, 2026: Option exercise of UTHR shares (Form 4, code M).
  • Mar 26, 2026: Open-market sales of UTHR shares (2 lines, Form 4, code S).
  • Mar 4, 2026: Open-market sale of UTHR shares (Form 4, code S).

Other insiders filing for UNITED THERAPEUTICS Corp (UTHR)

How to read Form 4 transaction codes